Targeted therapy using polymyxin B hemadsorption in patients with sepsis: a post-hoc analysis of the JSEPTIC-DIC study and the EUPHRATES trial

BACKGROUND: Polymyxin B hemadsorption (PMX-HA) reduces blood endotoxin levels, but characteristics of patients with sepsis likely to benefit from PMX-HA are not well known. We sought to identify patient subgroups likely to benefit from PMX-HA. METHODS: We retrospectively identified 1911 patients wit...

Descripción completa

Detalles Bibliográficos
Autores principales: Osawa, Itsuki, Goto, Tadahiro, Kudo, Daisuke, Hayakawa, Mineji, Yamakawa, Kazuma, Kushimoto, Shigeki, Foster, Debra M., Kellum, John A., Doi, Kent
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10286480/
https://www.ncbi.nlm.nih.gov/pubmed/37344804
http://dx.doi.org/10.1186/s13054-023-04533-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10286480/
https://www.ncbi.nlm.nih.gov/pubmed/37344804
http://dx.doi.org/10.1186/s13054-023-04533-3

Ejemplares similares